Kurs & Likviditet
Beskrivning
Land | Norge |
---|---|
Lista | OB Match |
Sektor | Hälsovård |
Industri | Bioteknik |
2021-03-08 17:44:39
Oslo, 8 March 2021, the Board of Directors of Ultimovacs ASA (the "Company") has
resolved to increase the Company's share capital by NOK 2,975 through the
issuance of 29,750 new shares, each with a par value of NOK 0.10. The resolution
is based on an authorisation to increase the share capital granted by the
Company's general meeting on 23 April 2020.
The new shares are issued to employees of the Company in connection with the
Company's employee incentive program. The new shares are issued at a
subscription price of NOK 31.25.
Following registration of the share capital increase with the Norwegian Register
of Business Enterprises, the Company will have a share capital of NOK
3,200,326.1, divided into 32,003,261 shares, each with a par value of NOK 0.10.
For further information, please contact:
Jónas Einarsson, Chairman of the Board of Directors of Ultimovacs ASA
Email: je@radforsk.no
Phone: +47 480 96 355
Carlos de Sousa, CEO
Email: carlos.desousa@ultimovacs.com
Phone: +47 908 92507
Hans Vassgård Eid, CFO
Email: hans.eid@ultimovacs.com
Phone: +47 482 48632